Market Research Logo

Europe Anesthesia Drugs Market - Segmented by Drug Type, Route of Administration, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)

Europe Anesthesia Drugs Market - Segmented by Drug Type, Route of Administration, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)

The European anesthesia drugs market is expected to register a CAGR of 2.4% during the forecast period (2018 - 2023). Anesthetic is a drug which causes anesthesia, it is a reversible loss of sensation. There are several types of anesthesia drugs available in the market such as the general anesthesia, spinal anesthesia, IV regional anesthesia, local anesthesia, peripheral nerve block, and saddle block or caudal anesthesia, etc.

Rise in the Number of Surgeries

According to a National Health Service (NHS), in 2013-2014, there were an estimated 4.7 million surgical admissions in England, among all the surgeries, general surgeries, trauma, and orthopedic procedures were the most common ones. The number of surgeries being performed is rising every year. The overall increase in the number of surgeries performed has a strong impact on the anesthetics market, as they are used in all surgical procedures to reduce the pain during surgery. Along with rising surgeries, factors such as new anesthetic drugs are also driving the market.

Side Effects of General Anesthesia

General anesthetic drugs cause several side-effects including nausea, vomiting, dry mouth, sore throat, shivering, muscle aches, disorientation, itching, sleepiness, and mild hoarseness. More serious complications of the drug include delirium, cognitive dysfunction, and malignant hyperthermia. General anesthetic drugs can cause physiological changes such as blood pressure variations which require a trained anesthesiologist to monitor the patient’s blood pressure levels continuously and might have to provide blood pressure medications. Carelessness or lack of knowledge of the anesthesiologist could pose as a potential risk. Hence, the side-effects of general anesthesia and patient’s reluctance towards using it are restraining the segment growth. The other factors such as lack of skilled anesthetics and regulatory issues are restraining the market growth.

General Anesthesia Drugs Segment to dominate the Market

General anesthesia drugs segment has the largest market share in the anesthesia drugs market. The major driving force that accounts for such growth in this segment is the increase in the number of general and emergency surgeries which require the use of general anesthesia drugs.

From the technology point of view, advancements in the development of new general anesthesia drugs are the prime driving force for this growth of the general anesthesia segment.

Key Developments in the Market

  • September 2017: AstraZeneca made an agreement with Aspen Global Incorporated (AGI).
  • April 2017: B. Braun and Philips joined forces to innovate in ultrasound-guided regional anesthesia and vascular access.
Major Players: BAXTER HEALTHCARE, HOSPIRA, ABBOTT LABORATORIES, ASTRA ZENECA, ROCHE HOLDING AG, B. BRAUN MELSUNGEN AG, ABBVIE, BOEHRINGER INGELHEIM, EISAI, FRESENIUS SE & CO. KGAA, among others.

Reasons to Purchase this Report
  • Current and future anesthesia drugs market outlook in the developed and emerging markets
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • Analysis on the segment that is expected to dominate the market
  • Countries that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet ((in Excel).
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.


1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Number of Surgeries
6.1.2 New Approvals of Anesthetic Drugs
6.2 Market Restraints
6.2.1 Side-Effects of General Anesthetics
6.2.2 Lack of skilled anesthesiologists
6.2.3 Regulatory Issues
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Type
7.1.1 General Anesthesia Drugs
7.1.1.1 Propofol
7.1.1.2 Sevoflurane
7.1.1.3 Desflurane
7.1.1.4 Dexmedetomidine
7.1.1.5 Remifentanil
7.1.1.6 Midazolam
7.1.1.7 Others
7.1.2 Local Anesthesia Drugs
7.1.2.1 Injectable Anesthetics
7.1.2.2 Surface Anesthetics
7.2 By Route of Administration
7.2.1 Inhalation
7.2.2 Injection
7.2.3 Others
7.3 By Application
7.3.1 General surgeries
7.3.2 Plastic Surgery
7.3.3 Cosmetic surgeries
7.3.4 Dental surgeries
7.3.5 Others
7.4 By Geography
7.4.1 Europe
7.4.1.1 France
7.4.1.2 Germany
7.4.1.3 United Kingdom
7.4.1.4 Italy
7.4.1.5 Spain
7.4.1.6 Rest Of Europe
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Baxter Healthcare
9.2 Hospira
9.3 Abbott Laboratories
9.4 Astra Zeneca
9.5 Roche Holding AG
9.6 Novartis
9.7 Pfizer
9.8 Boehringer Ingelheim
9.9 Others
*List not exhaustive
10. Future of the Market
11. Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report